The Use of Point-of-Care Ultrasound in the Diagnosis of Acute Infectious Mononucleosis in the Emergency Department

Sponsor
Jewish General Hospital (Other)
Overall Status
Terminated
CT.gov ID
NCT02463669
Collaborator
(none)
200
2
54.1
100
1.8

Study Details

Study Description

Brief Summary

The purpose of this study is to determine if splenomegaly on point-of-care ultrasound (POCUS) is an accurate and user-friendly surrogate to the heterophile antibody test and Epstein-Barr Virus (EBV) serologies to diagnose acute mononucleosis infection in patients presenting with sore throat to the Emergency Department (ED).

Condition or Disease Intervention/Treatment Phase
  • Device: Point-of-care ultrasound

Detailed Description

The investigators seek to determine whether the presence of splenomegaly on POCUS can accurately diagnose acute infectious mononucleosis in symptomatic ED patients, and determine the feasibility of performing point-of-care ultrasound for splenomegaly by emergency physicians in the emergency department setting.

Study Design

Study Type:
Observational
Actual Enrollment :
200 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
The Use of Point-of-Care Ultrasound in the Diagnosis of Acute Infectious Mononucleosis in the Emergency Department
Study Start Date :
Apr 1, 2016
Actual Primary Completion Date :
Oct 4, 2020
Actual Study Completion Date :
Oct 4, 2020

Outcome Measures

Primary Outcome Measures

  1. Presence of splenomegaly (maximal splenic cranio-caudal length) on point-of-care ultrasound [12 months]

    Splenomegaly is defined as a splenic length of > 11.5 centimetres (cm) for 10-12 year-old patients, > 12 cm for 12-15 year-old patients, > 12 cm for 15-35 year-old female patients, and > 13 cm for 15-35 year-old male patients.

Eligibility Criteria

Criteria

Ages Eligible for Study:
10 Years to 35 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Patients aged between 10 and 35 year-old presenting to the ED with suspected acute infectious mononucleosis
Exclusion Criteria:
  • Chronic infectious disorders (eg. tuberculosis, malaria, HIV, syphilis)

  • Inflammatory disorders (eg. sarcoidosis, amyloidosis, systemic lupus erythematosus, Felty syndrome)

  • Proliferative disorders (eg. lymphoma, leukemia, essential thrombocytopenia, polycythemia vera)

  • Congestive disorders (eg: cirrhosis, portal hypertension, right heart failure, congenital heart disease)

  • Chronic haemolytic anemia (eg. sickle cell, thalassemia, hereditary spherocytosis)

  • Storage diseases (eg. Gaucher, Niemann-Pick)

  • Splenectomy

  • Inability to give informed consent

Contacts and Locations

Locations

Site City State Country Postal Code
1 CHU Sainte-Justine Montreal Quebec Canada H3T 1C4
2 Jewish General Hospital Montreal Quebec Canada H3T 1E2

Sponsors and Collaborators

  • Jewish General Hospital

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Laurie Robichaud, Laurie Robichaud, MD, Jewish General Hospital
ClinicalTrials.gov Identifier:
NCT02463669
Other Study ID Numbers:
  • POCUSIM01
First Posted:
Jun 4, 2015
Last Update Posted:
Oct 6, 2020
Last Verified:
Oct 1, 2020
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Keywords provided by Laurie Robichaud, Laurie Robichaud, MD, Jewish General Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 6, 2020